Novel Drug Delivery – Beyond the Needle
Over 30 billion injections are administered per year. That’s five injections for every human being on the planet! Interstitial NanoSystems is dedicated to developing new forms of drug engineering, formulation and delivery to increase the effectiveness and reduce the pain and trauma associated with injections. Since 2006, Interstitial NS has become an industry leading commercial agent for next generation drug delivery technologies.
Interstitial NS is the specialist vehicle launched from the BioNano activities of Nanotechnology Victoria Ltd and established for the commercialisation of therapeutic nanoparticle delivery systems.
Download the Interstitial NS brochure (PDF)
|